Biomedical applications of nanoscaled magnets

 -> our publications in this field.


Fig.: Functionalised Carbon Nanotube with different fillling and biofunctional deviatisation of the outer shell.






Strong adverse effects on the healthy tissue in the vicinity of a tumour are a major drawback in current cancer therapies. One innovative technological approach to solve this problem focuses on therapies at the cellular level by applying intracellular probes, i.e. the transfer of nano-sized biocompatible devices into the cells. These devices (particles) must meet the demands of targeted investigation of relevant cell parameters as well as manipulation of the cells. When the transferred nanoparticles exhibit ferromagnetic properties, external magnetic fields can be used for manipulation in deep layers of (human) tissue since they provide a unique way to penetrate tissue non-invasively and without known adverse effects. External static magnetic fields fix the ferromagnetic nanoparticles at a precise position; gradient fields move them and alternating (AC) fields lead to local heating. The latter can be utilized for so-called ?hyperthermia?, i.e. a therapeutic anti-cancer treatment to raise the temperature of tumor tissue in-vivo.  This method applies the fact that a cancer cell-killing effect is caused when a temperature above 42?C is maintained in the target volume.

The long-term objective of the research programme is to exploit the potential of carbon-encapsulatedmagnets such as filled carbon nanotubes for human medical applications - with a focus on anti-tumour treatment - which allow targeted release of heat and/or drugs in cancer cells. The nano-devices will act as magnetic nano-heaters, drug-carrier systems and temperature sensors for therapy and diagnosis at the cellular level. To be specific, we: 

  • Synthesize CNT with tailored functionalities (different filling, heat sensitive caps)
  • Modify them in order to become compatible to actual biological systems
  • Study their chemical and physical properties in order to find mechanisms, which can be applied for a certain biomedical purpose in appropriate medical devices
  • Apply them for imaging (nanoparticles-based contrast agents), sensoring (nanoparticles-based diagnostics) and cancer treatment (hyperthermia, nanotechnology-based targeted drug delivery)

The usage of carbon-wrapped nanocontainers has several advantages, particularly, in medical applications. First, due to the protecting carbon shell, the number of materials which can be used for applications without toxic adverse effects strongly increases. Second, the outer shell of CNT can be chemically modified, e.g., with cancer-specific binding agents in order to enable attachment to a given tissue. Functionalized CNT can cross the cell membrane and accumulate in the cytoplasm or reach the nucleus without being toxic for the cell. Moreover, a possibility to functionalize the outer surface of CNT allows to control its solubility in physiological solutions not altering physical and chemical properties of encapsulated material. It was demonstrated that stable complex formation of CNT and cationic lipid may accelerate the delivery of nanotubes into bladder cancer human cells. Finally, the container feature of CNT allows simultaneous filling of CNT with a temperature sensor and another probe such as a ferromagnet (=heater), thereby combining different functionalities in one kind of CNT.

Selected Topics

  • AC magnetic heating for hyperthermia 
  • CNT as noninvasive in-vivo nanothermometers
  • Filling CNT with therapeutics
  • Combined chemotherapy and hyperthemia: Externally functionalised Fe-particles
  • Carbon-wrapped Fe/Co/Ni/FeCo/CoPt-nanoparticles


  • Marie-Curie Research Training Network CARBIO (Carbon Nanotubes for biomedical applications)
  • Leibniz-Institute for Solid State and Materials Research IFW Dresden
  • Department of Urology, University Hospital Carl Gustav Carus, TU Dresden, Germany
  • MPI-CBS (MPI for Molecular Cell Biology and Genetics)
  • Inter-University Research Center on Materials Engineering (CIRIMAT), University of Toulouse, France
  • Szczecin University of Technology, Centre of Knowledge Based Nanomaterials and Technologies (KnowMatTech)
  • Dep. of Hydrogen Technologies and Nanomaterials, Poland
  • MRC Immunochemistry Unit, Dep. of Biochemistry at the University of Oxford, UK
  • Institute for Biophysics, Johannes Kepler University of Linz, AustriaMolecular Genetics group, University of Surrey, Guildford, UKLow temperature division and Supramolecular Chemistry and Technology (SMCT/MESA+)University of Twente, Netherlands
  • Magforce Nanotechnologies AG, Berlin, Germany
zum Seitenanfang
The European Network CARBIO